Medtronic plc

NYSE:MDT

Medical - Devices

Healthcare
$100.72 +0.96%

+$0.75 today

Market cap
$128.84B
Beta
0.60
P/E (TTM)
21.1
EPS (TTM)
$3.74
Dividend yield
3.60%
52W Low $73.31High $106.33

Volume 6.47M

Average 11.36M

MDT Purchases of Investments

Cash used to buy marketable securities and other investments.

Medtronic plcNYSE: MDT

Purchases of Investments · Q1 FY2027 · quarter ended Jul 2026

Purchases of investments grows in line with its trailing trend

Q1 FY2027 purchases of investments of $2.19B (cash outflow) rose 4.3% year over year, in line with the +4.4% change in trailing-twelve-month purchases of investments. Sequentially, it rose 1.7% from the prior quarter. Over 3 fiscal years it compounded at +5.1% a year.

Context

  • Purchases of investments amounted to 24.0% of revenue in FY2026, down 0.5 pp from a year earlier.
  • Purchases of investments grew in size in 3 of the last 3 fiscal years.
  • FY2026 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +4.3% toward the trailing-twelve-month pace of +4.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJul 2026
-$2.19B+1.7% QoQ
Last fiscal yearApr 2026
-$8.73B+6.1% YoY
LTMJul 2026
-$8.82B+4.4% YoY
Purchases of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.3%——
1 year+6.1%——
3-year CAGR+5.1%——
5-year CAGR——
10-year CAGR——

Purchases of Investments history

USD · from the cash flow

Latest · FY2026
(8.73B) USD
Year-over-year change
-6.1%

Purchases of Investments vs competitors

How MDT compares with its peers on the latest reported figures

  • Peers report in different currencies, so purchases of investments is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +4.4% is the 6th highest of 7, against a peer median of +70.5%.
  • Purchases of investments amounts to 23.5% of revenue for MDT, versus a peer median of 2.0%.
MDT Competitors
Purchases of Investments for MDT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$8.82B USD+4.4%+5.1%23.5%
EWEdwards Lifesciences CorporationLTM Jun 2026$3.08B USD+40.0%+59.1%47.2%
BSXBoston Scientific CorporationLTM Jun 2026$1.8B USD——8.6%
PENPenumbra, Inc.LTM Jun 2026$713M USD+6026.5%—47.4%
ZBHZimmer Biomet Holdings, Inc.LTM Jun 2026$318M USD+36.3%+5.2%3.7%
PHGKoninklijke Philips N.V.LTM Jun 2026€53.81M EUR-43.2%—0.3%
SYKStryker CorporationLTM Jun 2026$8M USD+101.0%—0.0%
LIVNLivaNova PLCLTM Sep 2026$2.1M USD+609.5%+23.9%0.1%
AVRAnteris Technologies Global Corp.LTM Mar 2026$0 USD——0.0%
Peer median (excluding MDT) —+70.5%+23.9%2.0%

Competitors are the stored peer set for MDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
FY2026
Apr 2026
Net Income5.06B3.78B3.68B4.69B4.84B
Depreciation & Amortization2.71B2.7B2.65B2.86B2.96B
Deferred Income Tax(604M)(226M)(508M)(316M)51M
Stock-Based Compensation359M355M393M429M457M
Change in Working Capital(889M)(967M)(484M)(1.05B)(1.42B)
Accounts Receivables(477M)(576M)(391M)(433M)(200M)
Inventory(560M)(939M)(139M)(292M)(404M)
Accounts Payables213M696M391M209M46M
Other Working Capital(65M)(148M)(345M)(538M)(865M)
Other Non-Cash Items711M396M1.06B433M450M
Operating Cash Flow7.35B6.04B6.79B7.04B7.33B
Capital Expenditures(1.37B)(1.46B)(1.59B)(1.86B)(1.9B)
Acquisitions (Net)(91M)(1.87B)(211M)(98M)(406M)
Purchases of Investments(9.88B)(7.51B)(7.75B)(8.23B)(8.73B)
Sales of Investments9.69B7.34B7.44B8.5B8.11B
Other Investing Activities(10M)4M(261M)(249M)(4M)
Investing Cash Flow(1.66B)(3.49B)(2.37B)(1.94B)(2.93B)
Debt Repayment(1M)(598M)1.07B2.14B(1.17B)
Common Stock Issued429M308M284M508M516M
Common Stock Repurchased(2.54B)(645M)(2.14B)(3.24B)(1.04B)
Dividends Paid(3.38B)(3.62B)(3.67B)(3.59B)(3.64B)
Other Financing Activities163M(101M)(3M)(184M)582M
Financing Cash Flow(5.34B)(4.96B)(4.45B)(4.36B)(4.75B)
Effect of Forex Changes(230M)243M(230M)188M85M
Net Change in Cash121M(2.17B)(259M)934M(269M)
Free Cash Flow5.98B4.58B5.2B5.19B5.43B

Medtronic plc

NYSE:MDT

Intrinsic Alpha fair value

Locked

Current Price

$100.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.